| 101 | Mineralys Therapeutics Inc | 15 401 | 417,2 k $ | |
| 102 | Palisade Bio Inc | 236 348 | 413,6 k $ | |
| 103 | Voyager Therapeutics Inc | 107 094 | 413,4 k $ | |
| 104 | Cencora Inc | 1 216 | 382 k $ | |
| 105 | Compass Therapeutics Inc | 72 193 | 381,9 k $ | |
| 106 | Guardant Health Inc | 4 086 | 377,4 k $ | |
| 107 | Stryker Corp | 1 110 | 364,7 k $ | |
| 108 | Praxis Precision Medicines Inc | 1 131 | 364,4 k $ | |
| 109 | Antero Resources Corp | 8 101 | 358,3 k $ | |
| 110 | Relmada Therapeutics Inc | 50 773 | 353,4 k $ | |
| 111 | Biogen Inc | 1 903 | 348,9 k $ | |
| 112 | Jefferson Capital Inc | 17 775 | 341,8 k $ | |
| 113 | Trevi Therapeutics Inc | 27 913 | 333 k $ | |
| 114 | Mirum Pharmaceuticals Inc | 3 580 | 330,7 k $ | |
| 115 | UMB Financial Corp | 2 879 | 324,7 k $ | |
| 116 | PBF Energy Inc | 6 418 | 322,8 k $ | |
| 117 | Live Oak Bancshares Inc | 9 595 | 317,3 k $ | |
| 118 | Edgewise Therapeutics Inc | 10 053 | 316,7 k $ | |
| 119 | ConnectOne Bancorp Inc | 11 695 | 313,1 k $ | |
| 120 | Vaxcyte Inc | 5 319 | 309,1 k $ | |
| 121 | Regeneron Pharmaceuticals, Inc. | 400 | 309,1 k $ | |
| 122 | Dexcom Inc | 4 801 | 301,5 k $ | |
| 123 | Phathom Pharmaceuticals Inc | 26 766 | 297,4 k $ | |
| 124 | Humana Inc | 1 667 | 289 k $ | |
| 125 | Beacon Financial Corp | 9 354 | 280,6 k $ | |
| 126 | Zillow Group Inc | 6 657 | 275,5 k $ | |
| 127 | SAB Biotherapeutics Inc | 69 732 | 267,1 k $ | |
| 128 | BioAge Labs Inc | 15 167 | 265,3 k $ | |
| 129 | Maze Therapeutics Inc | 8 768 | 261,7 k $ | |
| 130 | Power Solutions International Inc | 4 295 | 261,5 k $ | |
| 131 | Enliven Therapeutics Inc | 6 606 | 259 k $ | |
| 132 | Full Truck Alliance Co Ltd | 30 811 | 255,7 k $ | |
| 133 | Aytu BioPharma Inc | 92 897 | 253,6 k $ | |
| 134 | Sea Ltd | 3 000 | 248,4 k $ | |
| 135 | INOVIO PHARMACEUTICALS INC | 142 164 | 247,4 k $ | |
| 136 | Thermo Fisher Scientific Inc | 503 | 247,2 k $ | |
| 137 | Spyre Therapeutics Inc | 4 803 | 242,3 k $ | |
| 138 | DBV Technologies SA | 11 392 | 238 k $ | |
| 139 | Adlai Nortye Ltd. | 33 732 | 233,4 k $ | |
| 140 | ZAI LAB LTD | 12 339 | 232,1 k $ | |
| 141 | CoreWeave Inc | 2 892 | 224 k $ | |
| 142 | New Oriental Education & Technology Group Inc | 3 956 | 224 k $ | |
| 143 | Foghorn Therapeutics Inc | 46 644 | 223 k $ | |
| 144 | Amneal Pharmaceuticals Inc | 17 808 | 221,4 k $ | |
| 145 | Equillium Inc | 110 117 | 220,2 k $ | |
| 146 | PASITHEA THERAPEUTICS CORP | 290 555 | 215,5 k $ | |
| 147 | Enanta Pharmaceuticals Inc | 16 525 | 208,7 k $ | |
| 148 | Surrozen Inc | 7 143 | 208,1 k $ | |
| 149 | Xeris Biopharma Holdings Inc | 35 661 | 206,8 k $ | |
| 150 | Solid Biosciences Inc | 27 990 | 201,5 k $ | |
| 151 | Lantheus Holdings Inc | 2 642 | 200,4 k $ | |
| 152 | Benitec Biopharma Inc | 18 307 | 195 k $ | |
| 153 | Replimune Group Inc | 25 445 | 194,7 k $ | |
| 154 | Larimar Therapeutics Inc | 42 124 | 189,6 k $ | |
| 155 | ArriVent Biopharma Inc | 8 108 | 187,1 k $ | |
| 156 | Annexon Inc | 33 625 | 186,3 k $ | |
| 157 | Ultragenyx Pharmaceutical Inc | 8 884 | 186,1 k $ | |
| 158 | Argenx SE | 253 | 184,8 k $ | |
| 159 | Sutro Biopharma Inc | 7 411 | 184,6 k $ | |
| 160 | KalVista Pharmaceuticals Inc | 9 001 | 181,2 k $ | |
| 161 | Unicycive Therapeutics Inc | 26 827 | 176,5 k $ | |
| 162 | Forte Biosciences Inc | 6 744 | 174,7 k $ | |
| 163 | Tyra Biosciences Inc | 4 518 | 173 k $ | |
| 164 | Arrowhead Pharmaceuticals Inc | 2 661 | 166,8 k $ | |
| 165 | SPRUCE BIOSCIENCES INC | 2 528 | 165,2 k $ | |
| 166 | Certara Inc | 28 623 | 163,2 k $ | |
| 167 | Relay Therapeutics Inc | 16 358 | 162,8 k $ | |
| 168 | GE HealthCare Technologies Inc | 2 237 | 159,2 k $ | |
| 169 | DAMORA THERAPEUTICS INC | 5 338 | 138,3 k $ | |
| 170 | ADAGENE INC | 35 126 | 137,7 k $ | |
| 171 | Novo Nordisk A/S | 3 685 | 135,4 k $ | |
| 172 | Personalis Inc | 20 929 | 133,3 k $ | |
| 173 | AN2 Therapeutics Inc | 38 155 | 130,5 k $ | |
| 174 | PELTHOS THERAPEUTICS INC | 6 007 | 126,2 k $ | |
| 175 | MKS Inc | 520 | 119,5 k $ | |
| 176 | AVALO THERAPEUTICS INC | 7 918 | 118,2 k $ | |
| 177 | MannKind Corp | 47 394 | 116,1 k $ | |
| 178 | Lipocine Inc | 13 442 | 107,4 k $ | |
| 179 | Corcept Therapeutics Inc | 2 528 | 101,9 k $ | |
| 180 | Adaptive Biotechnologies Corp | 6 689 | 92,8 k $ | |
| 181 | Ocugen Inc | 50 559 | 91,5 k $ | |
| 182 | Opus Genetics Inc | 17 919 | 81,5 k $ | |
| 183 | HUYA Inc | 22 273 | 73,5 k $ | |
| 184 | Invivyd Inc | 55 990 | 72,8 k $ | |
| 185 | PepGen Inc | 38 152 | 67,5 k $ | |
| 186 | Yatsen Holding Ltd | 20 151 | 62,1 k $ | |
| 187 | Precigen Inc | 13 978 | 54,1 k $ | |
| 188 | Upstream Bio Inc | 5 495 | 49,5 k $ | |
| 189 | Compass Pathways plc | 8 060 | 44,6 k $ | |
| 190 | Monopar Therapeutics Inc | 783 | 42,9 k $ | |
| 191 | Passage Bio Inc | 4 955 | 38,9 k $ | |
| 192 | Bloom Energy Corp | 245 | 33,2 k $ | |
| 193 | TALPHERA INC | 38 968 | 29,1 k $ | |
| 194 | Rocket Pharmaceuticals Inc | 7 731 | 27,7 k $ | |
| 195 | PURETECH HEALTH PLC | 1 759 | 26,1 k $ | |
| 196 | VISTAGEN THERAPEUTICS INC | 26 612 | 15,2 k $ | |
| 197 | CUE BIOPHARMA INC | 33 369 | 7,7 k $ | |
| 198 | Atrium Therapeutics Inc | 283 | 3,8 k $ | |
| 199 | Chevron Corp | 1 | 211 $ | |